Indications |
Oral Schizophrenia Adult: Initial dose: 10-15 mg once daily. Usual maintenance dose: 15 mg once daily. Adjust dose at intervals of at least 2 wk. Max dose: 30 mg once daily. Oral Acute manic episodes of bipolar disorder Adult: 30 mg once daily, decreased to 15 mg once daily based on tolerability. |
Contraindications |
Hypersensitivity. Lactation. Children <18 yr. |
Warnings / Precautions |
Patients with known CV diseases (e.g. history of MI, IHD, CCF or conduction abnormalities), cerebrovascular diseases or conditions which would predispose patients to hypotension; Alzheimer's disease and dementia. Caution when operating hazardous machinery, including automobiles when taking aripiprazole. Pregnancy. |
Adverse Reactions |
Headache, agitation, insomnia, somnolence; dyspepsia, constipation, pain, nausea, vomiting; asthaenia, dizziness, abdominal pain; dry mouth; anxiety, akathisia; orthostatic hypotension; hypertonia, tremor and blurred vision. |
Overdose Reactions |
Symptoms include nausea, vomiting, asthenia, diarrhoea and somnolence. |
Drug Interactions |
Drugs that induce CYP3A4 (e.g. carbamazepine) could cause an increase in aripiprazole clearance and lower blood levels. Inhibitors of CYP3A4 (e.g. ketoconazole) or CYP2D6 (e.g. quinidine, fluoxetine or paroxetine) can inhibit aripiprazole elimination and cause increased blood levels. Increased CNS depression with ethanol. See Below for More aripiprazole Drug Interactions |
Food Interactions |
Ingestion with a high-fat meal delays time to peak plasma level. |
Mechanism of Actions |
Aripiprazole acts as a partial agonist at D2 and 5-HT1A receptors and as an antagonist at 5-HT2A receptors. Absorption: Well absorbed from the GI tract. Absolute bioavailability: about 87%. Distribution: Protein binding: about 99%. Metabolism: Mainly in the liver and the pathways involved include dehydrogenation and hydroxylation. Excretion: About 55% excreted in faeces and 25% in urine, mainly in the form of metabolites. |
Administration |
May be taken with or without food. |
ATC Classification |
N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics. |
Available As |
|
Aripiprazole
Post Review about Aripiprazole Click here to cancel reply.
Aripiprazole Containing Brands
Aripiprazole is used in following diseases
Drug - Drug Interactions of Aripiprazole
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.